117 related articles for article (PubMed ID: 2988158)
1. A secondary prevention, randomized trial of suloctidil in patients with a recent history of thromboembolic stroke.
Gent M; Blakely JA; Hachinski V; Roberts RS; Barnett HJ; Bayer NH; Carruthers SG; Collins SM; Gawel MG; Giroux-Klimek M
Stroke; 1985; 16(3):416-24. PubMed ID: 2988158
[TBL] [Abstract][Full Text] [Related]
2. Hypocholesterolaemic activity of suloctidil: double-blind, crossover short-term and long-term treatment trial.
Chieffo C; Postiglione A; Tritto C; Mancini M
Curr Med Res Opin; 1984; 9(3):147-52. PubMed ID: 6094103
[TBL] [Abstract][Full Text] [Related]
3. Double-blind trial of suloctidil versus placebo in moderate to severe mental deterioration.
Baro F; Malfroid M; Waegemans T; Cox JP
Pharmatherapeutica; 1985; 4(6):399-404. PubMed ID: 3001778
[TBL] [Abstract][Full Text] [Related]
4. Effect of suloctidil on platelet function in patients with shortened platelet survival time.
Turpie AG; Gent M; deBoer AC; Giroux M; Kinch D; Butt R; Gunstensen J; Saerens E; Genton E
Thromb Res; 1984 Aug; 35(4):397-406. PubMed ID: 6091290
[TBL] [Abstract][Full Text] [Related]
5. Controlled trial of suloctidil in intermittent claudication.
Verhaeghe R; Van Hoof A; Beyens G
J Cardiovasc Pharmacol; 1981; 3(2):279-86. PubMed ID: 6166799
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of suloctidil in the prevention of deep vein thrombosis in neurosurgical patients.
Turpie AG; Gent M; Doyle DJ; Saerens E; de Boer AC; Talbot C; McNamee J; Hirsh J
Thromb Res; 1985 Jul; 39(2):173-81. PubMed ID: 2992116
[TBL] [Abstract][Full Text] [Related]
7. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke.
Gent M; Blakely JA; Easton JD; Ellis DJ; Hachinski VC; Harbison JW; Panak E; Roberts RS; Sicurella J; Turpie AG
Lancet; 1989 Jun; 1(8649):1215-20. PubMed ID: 2566778
[TBL] [Abstract][Full Text] [Related]
8. Suloctidil: long-term trial in the aged. Study of microcirculation, viscosity, red cell deformability, fibrinolysis and lipid fractions.
Merchan R; Zurita IE; Martinez JF
Arzneimittelforschung; 1985; 35(5):855-7. PubMed ID: 2992530
[TBL] [Abstract][Full Text] [Related]
9. A double-blind trial of suloctidil v. placebo in intermittent claudication.
Jones NA; De Haas H; Zahavi J; Kakkar VV
Br J Surg; 1982 Jan; 69(1):38-40. PubMed ID: 6274471
[TBL] [Abstract][Full Text] [Related]
10. [Clinical trial of suloctidil (sulocton) for the treatment of migraine (preliminary report)].
Prusiński A
Neurol Neurochir Pol; 1981; 15(3):309-11. PubMed ID: 6273762
[TBL] [Abstract][Full Text] [Related]
11. Suloctidil-induced hepatotoxicity.
Chung MW; Komorowski RA; Varma RR
Gastroenterology; 1988 Aug; 95(2):490-1. PubMed ID: 2839389
[TBL] [Abstract][Full Text] [Related]
12. Effect of suloctidil on tomographically quantitated platelet accumulation in Dacron aortic grafts.
Stratton JR; Ritchie JL
Am J Cardiol; 1986 Jul; 58(1):152-6. PubMed ID: 3014851
[TBL] [Abstract][Full Text] [Related]
13. Combination of suloctidil and anticoagulation in the prevention of reocclusion after femoro-popliteal PTA.
Mahler F; Schneider E; Gallino A; Bollinger A
Vasa; 1987; 16(4):381-5. PubMed ID: 2827398
[No Abstract] [Full Text] [Related]
14. Suloctidil therapy in migraine: an open pilot study.
Prusiński A; Durko A; Głuszcz-Zielińska A; Szymańska R
Curr Med Res Opin; 1983; 8(9):631-3. PubMed ID: 6321107
[TBL] [Abstract][Full Text] [Related]
15. Intermittent claudication: Suloctidil v.s. placebo treatment.
Holm J; Lindblad L; Scherstén T; Suurkula M
Vasa; 1984; 13(2):175-8. PubMed ID: 6331019
[No Abstract] [Full Text] [Related]
16. [Medical therapy of chronic obstructive arteriopathy of the lower extremities. A controlled clinical study of suloctidil versus xanthinol].
Spinella G; Majorana M
Clin Ter; 1983 Mar; 104(5):375-81. PubMed ID: 6303677
[No Abstract] [Full Text] [Related]
17. [Suloctidil in the treatment of focal cerebral ischemia].
Bartko D; Zúzi M; Brezná M; Trávniková M; Porubec V
Cesk Neurol Neurochir; 1984 Mar; 47(2):103-8. PubMed ID: 6323038
[No Abstract] [Full Text] [Related]
18. Clinical and biological activity of the antiplatelet agent suloctidil in treatment of idiopathic recurrent vein thrombosis (I.R.V.T.).
Moriau M; Col-De Beys C; Pardonge E; Ferrant A
Thromb Haemost; 1982 Feb; 47(1):27-31. PubMed ID: 6280332
[TBL] [Abstract][Full Text] [Related]
19. [Further observations on the use of Suloctidil (Sulocton) in the treatment of migraine].
Prusiński A; Durko A; Głuszcz-Zielińska A; Szymańska R
Wiad Lek; 1984 Dec; 37(23):1857-9. PubMed ID: 6099634
[No Abstract] [Full Text] [Related]
20. [Trial of a new drug in Raynaud's disease. Clinical and thermographic control].
Dumoulin J
Electrodiagn Ther; 1981; 18(4):168-74. PubMed ID: 6279383
[No Abstract] [Full Text] [Related]
[Next] [New Search]
